Last reviewed · How we verify

NCT04848701

Uterocervical Angle: a Screening Tool That Estimates the Latent Phase Duration in Post Term Pregnancies

Completed NA Last updated 19 April 2021
What this trial tests

NA trial testing latent phase duration in Post Term Pregnancy in 90 participants. Completed in 30 October 2020.

Timeline
1 June 2020
Primary endpoint
30 October 2020
30 October 2020

Quick facts

Lead sponsorSanliurfa Mehmet Akif Inan Education and Research Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposescreening
Enrollment90
Start date1 June 2020
Primary completion30 October 2020
Estimated completion30 October 2020
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Sanliurfa Mehmet Akif Inan Education and Research Hospital

Who can join

Adults 18 to 40, female only, with Post Term Pregnancy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the performance of uterocervical angle (UCA) in the prediction of latent phase duration in post term pregnancies

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Post Term Pregnancy

Currently open trials in the same condition.

Other Sanliurfa Mehmet Akif Inan Education and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04848701.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing